[ad_1]
Regulators have issued a warning that people who have a history of “significant” allergic reactions should not currently receive the Pfizer / BioNTech Covid-19 vaccine after two people who received the injection Tuesday had allergic reactions.
Two NHS staff members in the UK who received the vaccine on the first day of the mass vaccination program suffered an allergic reaction, the NHS in England confirmed.
Both staff members are understood to have a significant history of allergic reactions, to the extent that they need to carry an adrenaline auto-injector.
They were among the thousands who received the vaccine on Tuesday.
The Medicines and Healthcare Products Regulatory Agency (MHRA) has given cautionary advice to the NHS trusts that anyone who has a history of “significant” allergic reactions to drugs, foods or vaccines should not receive the vaccine.
The NHS in England said that all trusts involved with the vaccination program have been informed.
This means that anyone scheduled to receive the vaccine on Wednesday will be asked about their history of allergic reactions.
Professor Stephen Powis, National Medical Director of the NHS in England, said: “As is common with new vaccines, the MHRA has advised as a precaution that people with a significant history of allergic reactions should not receive this vaccine after two people with a The history of major allergic reactions responded negatively yesterday.
“They are both recovering well.”
The MHRA advice states: “Anyone with a history of a significant allergic reaction to a vaccine, drug, or food (such as a prior history of an anaphylactoid reaction or those who have been recommended to carry an adrenaline autoinjector) should not receive the Pfizer / BioNtech vaccine.
“Resuscitation facilities must be available at all times for all vaccinations. Vaccination should only be carried out in facilities where resuscitation measures are available. “
They developed symptoms of an “anaphylactoid reaction” shortly after receiving the vaccine and both recovered after appropriate treatment.
[ad_2]